HomeMIRA • NASDAQ
add
Mira Pharmaceuticals Inc
Previous close
$1.42
Day range
$1.38 - $1.53
Year range
$0.51 - $5.01
Market cap
24.53M USD
Avg Volume
2.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.81M | 2.09% |
Net income | -1.78M | -3.84% |
Net profit margin | — | — |
Earnings per share | -0.11 | 8.33% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.21M | -65.81% |
Total assets | 1.40M | -63.23% |
Total liabilities | 106.17K | -83.72% |
Total equity | 1.29M | — |
Shares outstanding | 16.92M | — |
Price to book | 17.75 | — |
Return on assets | -208.77% | — |
Return on capital | -258.33% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.78M | -3.84% |
Cash from operations | -1.63M | -55.31% |
Cash from investing | — | — |
Cash from financing | 3.38K | 113.89% |
Net change in cash | -1.63M | -51.47% |
Free cash flow | -1.85M | -323.30% |
About
Founded
2020
Headquarters
Website
Employees
3
